← Scroll for more →
Financial Statements — CGEN
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 90.60 | 6.47 | 18.23 | 11.88 | 13.89 | 17.07 | 11.06 | 8.01 | 7.80 | 7.85 |
| Short-term Investments | 9.28 | 28.88 | 23.63 | 32.69 | 11.74 | 4.55 | -- | -- | -- | -- |
| Accounts Receivable | -- | -- | 0.00 | 5.00 | 61.00 | -- | -- | -- | 2.00 | 2.00 |
| Total Current Assets | 148.02 | 97.64 | 106.00 | 102.13 | 114.58 | 69.40 | 86.13 | 101.98 | 123.22 | 113.75 |
| Property, Plant & Equipment | 0.68 | 0.84 | 0.85 | 1.03 | 1.22 | 1.35 | 1.53 | 1.60 | 1.66 | 1.72 |
| Total Non-current Assets | 8.55 | 8.88 | 9.00 | 8.03 | 6.76 | 7.66 | 8.05 | 8.33 | 8.94 | 9.06 |
| Total Assets | 156.57 | 106.53 | 115.00 | 110.17 | 121.33 | 77.06 | 94.18 | 110.31 | 132.16 | 122.82 |
| Accounts Payable | 2.35 | 1.79 | 1.84 | 2.38 | 3.50 | 1.68 | 1.77 | 2.15 | 4.62 | 1.81 |
| Total Current Liabilities | 22.57 | 20.58 | 20.16 | 24.77 | 26.27 | 10.80 | 11.92 | 14.00 | 17.10 | 11.85 |
| Total Non-current Liabilities | 31.27 | 35.69 | 39.92 | 27.06 | 29.51 | 4.25 | 4.58 | 5.94 | 8.37 | 7.55 |
| Total Liabilities* | 53.84 | 56.27 | 60.08 | 51.83 | 55.78 | 15.05 | 16.50 | 19.93 | 25.47 | 19.40 |
| Retained Earnings | (453.41) | (503.28) | (488.76) | (483.92) | (474.53) | (474.39) | (455.77) | (440.93) | (422.08) | (407.28) |
| Total Stockholder Equity | 102.73 | 50.26 | 54.91 | 58.34 | 65.56 | 62.00 | 77.68 | 90.38 | 106.69 | 103.42 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Total Revenue | 3.54 | 9.26 | -- | -- | -- |
| Cost of Revenue | 4.07 | 3.65 | -- | -- | -- |
| Gross Profit | (0.52) | 5.61 | -- | -- | -- |
| Research & Development | 11.41 | 12.59 | 15.21 | 13.98 | 14.12 |
| Selling, General & Admin | 4.61 | 4.67 | 4.98 | 5.17 | 5.37 |
| Total Operating Expenses | 16.30 | 17.51 | 20.35 | 19.63 | 19.96 |
| Operating Income | (16.82) | (11.90) | -- | -- | -- |
| Pretax Income | (14.51) | (9.38) | (18.65) | (18.85) | (19.40) |
| Tax Provision | 0.01 | 0.01 | (0.04) | 0.00 | -- |
| Net Income | (14.52) | (9.39) | (18.61) | (18.85) | (19.40) |
| Basic EPS | (0.16) | (0.10) | 0.21 | 0.22 | -- |
| Diluted EPS | (0.16) | (0.10) | 0.21 | 0.22 | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | (18.56) | 39.70 | (18.62) | (20.68) | (13.63) |
| Capital Expenditures | 0.23 | 0.04 | 0.06 | 0.26 | 0.22 |
| Free Cash Flow* | (18.79) | 39.67 | (18.68) | (20.94) | (13.85) |
| Investing Cash Flow | (2.27) | (42.29) | 23.53 | 20.19 | 13.44 |
| Financing Cash Flow | 8.90 | 0.56 | 1.35 | 0.35 | 0.91 |
← Scroll for more columns →
* Derived from reported values